Volume 7 / Number 1 / 2018
Biopharmaceuticals-medicines produced from living cells- have emerged recently and already are having a revolutionary impact on vexing diseases such as cancer.
But meeting demand for these treatments requires a faster, more streamlined manufacturing process for making safe, efficacious medicines in the future.
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), headquartered at the University of Delaware, is at the forefront of making these medicines more accessible to Americans.
Select an edition to read more.
SUBSCRIBE & CONNECT
The University of Delaware Research magazine, a free publication issued three times a year, showcases the discoveries, inventions and excellence of the University’s faculty, staff and students. Sign up for a free subscription.